Establishment of the nationwide Norwegian Prescription Database (NorPD) - New opportunities for research in pharmacoepidemiology in Norway

Norsk Epidemiologi

Volumn 18, Issue 2, 2008, Pages 129-136

  Furu, Kari ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSTATISTICS; DATA BASE; DECISION MAKING; DRUG UTILIZATION; HEALTH SURVEY; HUMAN; INFORMATION PROCESSING; LONGITUDINAL STUDY; NORWAY; PHARMACOEPIDEMIOLOGY; PHARMACY; POPULATION RESEARCH; PRESCRIPTION; PREVALENCE; PUBLIC HEALTH SERVICE; RELIABILITY; REVIEW; VALIDITY;

EID: 45549098153     PISSN: 08032491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Furu K. Drug utilisation in a public health perspective: Establishing a national prescription register in Norway. Nor J Epidemiol 2001; 11 (1): 55-60.
2. Furu K. Etablering av et reseptbasert legemiddelregister. Notat av 30.april 2002. Folkehelseavdelingen, Helsedepartementet, 2002.
3. Stortingsproposisjon 1 (Statsbudsjettet 2002-2003), 2002.
4. Strøm H. Reseptbasert legemiddelregister: Et viktig verktey for å oppnå detaljert legemiddelstatistikk. Nor J Epidemiol 2004; 14 (1): 53-55.
5. [Forskrift om innsamling og behandling av helseopplysninger i Reseptbasert legemiddelregister (Reseptregisteret)], 20-10-2003.
6. Personal Health Data Filing System Act [Helseregisterloven]. Act of 18 May 2001 No. 24, 18-5-2001.
7. Rønning M, Litleskare I, Addis A et al. Recommendations for national registers of medicinal products with validated ATC codes and DDD values. Ital J Public Health 2006; 3 (1): 30-35.
8. Furu K, Skurtveit S, Langhammer A, Nafstad P. Use of anti-asthmatic medications as a proxy for prevalence of asthma in children and adolescents in Norway: a nationwide prescription database analysis. Eur J Clin Pharmacol 2007; 63 (7): 693-698.
9. Bramness JG, Furu K, Engeland A, Skurtveit S. Carisoprodol use and abuse in Norway: a pharmacoepidemiological study. Br J Clin Pharmacol 2007; 64 (2): 210-218.
10. Sakshaug S, Furu K, Karlstad Ø, Rønning M, Skurtveit S. Switching statins in Norway after new reimbursement policy: a nationwide prescription study. Br J Clin Pharmacol 2007; 64 (4): 476-481.
11. Engeland A, Bramness JG, Daltveit AK, Rønning M, Skurtveit S, Furu K. Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-2006. Br J Clin Pharmacol 2008; 65 (5): 653-660.
12. Begg EJ. Prescribing in pregnancy and lactation. Br J Clin Pharmacol 2008; 65 (5): 627-628.
13. West SL, Strom BL, Poole C. Validity of pharmacoepidemiology drug and diagnosis data. In: Strom BL, ed. Pharmacoepidemiology, 3rd edn. John Wiley & Sons, 2000: 661-705.
14. Beardon PH, McGilchrist MM, McKendrick AD, McDevitt DG, MacDonald TM. Primary non-compliance with prescribed medication in primary care. BMJ 1993; 307 (6908): 846-848.
15. West SL, Strom BL, Freundlich B, Normand E, Koch G, Savitz DA. Completeness of prescription recording in outpatient medical records from a health maintenance organization. J Clin Epidemiol 1994; 47 (2): 165-171.
16. West SL, Savitz DA, Koch G, Strom BL, Guess HA, Hartzema A. Recall accuracy for prescription medications: self-report compared with database information. Am J Epidemiol 1995; 142 (10): 1103-1112.
17. Skegg DC, Doll R. Record linkage for drug monitoring. J Epidemiol Community Health 1981; 35 (1): 25-31.
18. Stricker BH. Drug safety epidemiology: time for Europe to start using this instrument. Eur J Epidemiol 2003; 18 (4): 287-288.